3 results match your criteria: "Bristol and Royal National Hospital for Rheumatic Diseases[Affiliation]"
Current Evidence-Based Interdisciplinary Treatment Options for Pediatric Musculoskeletal Pain.
Curr Treatm Opt Rheumatol
June 2018
2Centre for Pain Research, University of Bath, Bath, UK.
Purpose Of Review: We review the prevalence of pediatric chronic musculoskeletal pain, the clinical need, the evidence for pharmacological, psychological, physical and, complementary approaches to pain management, and the possible future development of interdisciplinary and distance care.
Recent Findings: We summarize the Cochrane Systematic Reviews on pharmacological interventions, which show a lack of evidence to support or refute the use of all classes of medication for the management of pain. The trials for NSAIDs did not show any superiority over comparators, nor did those of anti-depressants, and there are no trials for paracetamol, or of opioid medications.
Phase II Pragmatic Randomized Controlled Trial of Patient-Led Therapies (Mirror Therapy and Lower-Limb Exercises) During Inpatient Stroke Rehabilitation.
Neurorehabil Neural Repair
October 2015
University of Manchester, Manchester, UK Salford Royal NHS Foundation Trust, UK.
Background And Objective: Patient-led therapy has the potential to increase the amount of therapy patients undertake during stroke rehabilitation and to enhance recovery. Our objective was to assess the feasibility and acceptability of 2 patient-led therapies during the acute stages of stroke care: mirror therapy for the upper limb and lower-limb exercises for the lower limb.
Methods: This was a blind assessed, multicenter, pragmatic randomized controlled trial of patient-led upper-limb mirror therapy and patient-led lower leg exercises.
Recognition and management of macrophage activation syndrome in juvenile arthritis.
Curr Opin Rheumatol
September 2007
Department of Paediatric Rheumatology, Bristol Royal Hospital for Children, Bristol and Royal National Hospital for Rheumatic Diseases, Bath, UK.
Purpose Of Review: Macrophage activation syndrome is a life-threatening complication seen predominantly in children with systemic onset juvenile idiopathic arthritis. It accounts for a significant amount of the morbidity and mortality seen with systemic onset juvenile idiopathic arthritis.
Recent Findings: In this article, we will look at the new developments in the diagnosis, classification, pathogenesis and management of macrophage activation syndrome in systemic onset juvenile idiopathic arthritis patients.